TY  - GEN
AU  - Ojima,Ayako
AU  - Ishibashi,Yuji
AU  - Matsui,Takanori
AU  - Maeda,Sayaka
AU  - Nishino,Yuri
AU  - Takeuchi,Masayoshi
AU  - Fukami,Kei
AU  - Yamagishi,Sho-ichi
TI  - Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression
SN  - 1525-2191
PY  - 2013///0606
KW  - Animals
KW  - Arginine
KW  - analogs & derivatives
KW  - Diabetes Mellitus, Experimental
KW  - drug therapy
KW  - Diabetic Nephropathies
KW  - Drug Evaluation, Preclinical
KW  - methods
KW  - Exenatide
KW  - Gene Expression Regulation, Enzymologic
KW  - drug effects
KW  - Glucagon-Like Peptide 1
KW  - pharmacology
KW  - Glucagon-Like Peptide-1 Receptor
KW  - Glycation End Products, Advanced
KW  - physiology
KW  - Humans
KW  - Hypertrophy
KW  - prevention & control
KW  - Hypoglycemic Agents
KW  - Kidney
KW  - metabolism
KW  - Kidney Glomerulus
KW  - pathology
KW  - Kidney Tubules
KW  - Macrophages
KW  - Male
KW  - Peptides
KW  - Protein-Arginine N-Methyltransferases
KW  - biosynthesis
KW  - RNA, Messenger
KW  - genetics
KW  - Rats
KW  - Rats, Wistar
KW  - Reactive Oxygen Species
KW  - Receptor for Advanced Glycation End Products
KW  - Receptors, Glucagon
KW  - agonists
KW  - Receptors, Immunologic
KW  - Repressor Proteins
KW  - Venoms
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ajpath.2012.09.016
ER  -